FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017191741> ?p ?o ?g. }

• W2017191741 endingPage "278" @default.
• W2017191741 startingPage "271" @default.
• W2017191741 abstract "This study was designed to test the hypothesis that the sphingomyelin-ceramide signaling pathway may be important in proinflammatory-like responses in the intact brain. Effects of neutral sphingomyelinase (N-SMase), ceramide analogs, phosphorylcholine and ceramide metabolites were studied on rat brain cerebral (cortical) venule lumen sizes, leukocyte rolling, velocity and endothelial cell wall adhesion, microvessel permeability, microvessel rupture and focal hemorrhages using in vivo high resolution TV microscopy. Perivascular and close intra-arterial administration of N-SMase, C(2)-, C(8)-, and C(16)-ceramide, but not either phosphorylcholine, C(6)-ceramide, nervonic (C(24):1) ceramide, lignoceric (C(24):0) ceramide, C(8)-ceramide-1-phosphate, glucosylceramide or 1-0-acylceramide, resulted in potent, concentration-dependent constriction (and spasm) of cortical venules, followed by increased leukocyte rolling, decreased leukocyte velocities, increased leukocyte-endothelial wall adhesion, increased venular wall permeability, postcapillary venule rupture and, often, micro-hemorrhaging at high concentrations; angiotensin II, serotonin and PGF(2alpha) didn't demonstrate these characteristics. Pretreatment with either one of three different antioxidants, including inhibitors of NF-kappaB activation, or two different Ca(2+) channel blockers either prevented or attenuated the adverse venular effects of N-SMase and the ceramides. Likewise, pretreatment with either a PKCalpha-beta antagonist or a MAP kinase antagonist also attenuated the adverse venular effects. These results suggest that N-SMase and several ceramides can result in potent venular cerebrovasospasm, leukocyte-endothelial chemoattraction, and microvessel wall permeability changes in the intact rat brain. These proinflammatory-like actions suggest that N-SMase and ceramides could produce brain-vascular damage by reperfusion injury triggering lipid peroxidation, release of reactive oxygen species and activation of diverse signaling pathways: PKCalpha-beta isozymes, MAP kinase and NF-kappaB." @default.
• W2017191741 created "2016-06-24" @default.
• W2017191741 creator A5002673572 @default.
• W2017191741 creator A5012953142 @default.
• W2017191741 creator A5013614593 @default.
• W2017191741 creator A5089404274 @default.
• W2017191741 date "2002-07-01" @default.
• W2017191741 modified "2023-09-27" @default.
• W2017191741 title "Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte–endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke" @default.
• W2017191741 cites W1510210099 @default.
• W2017191741 cites W1565998937 @default.
• W2017191741 cites W1566441785 @default.
• W2017191741 cites W1966540696 @default.
• W2017191741 cites W1968603149 @default.
• W2017191741 cites W1970655844 @default.
• W2017191741 cites W1972392437 @default.
• W2017191741 cites W1973902581 @default.
• W2017191741 cites W1974961267 @default.
• W2017191741 cites W1981412298 @default.
• W2017191741 cites W1981707898 @default.
• W2017191741 cites W1990082709 @default.
• W2017191741 cites W1993597367 @default.
• W2017191741 cites W1994010467 @default.
• W2017191741 cites W2005879992 @default.
• W2017191741 cites W2012854919 @default.
• W2017191741 cites W2020807000 @default.
• W2017191741 cites W2024916451 @default.
• W2017191741 cites W2029907745 @default.
• W2017191741 cites W2030783122 @default.
• W2017191741 cites W2040470926 @default.
• W2017191741 cites W2041767551 @default.
• W2017191741 cites W2042628846 @default.
• W2017191741 cites W2046571710 @default.
• W2017191741 cites W2056084766 @default.
• W2017191741 cites W2059062880 @default.
• W2017191741 cites W2064364405 @default.
• W2017191741 cites W2076238417 @default.
• W2017191741 cites W2080475643 @default.
• W2017191741 cites W2088094960 @default.
• W2017191741 cites W2089752954 @default.
• W2017191741 cites W2091578889 @default.
• W2017191741 cites W2093317801 @default.
• W2017191741 cites W2096012158 @default.
• W2017191741 cites W2126544407 @default.
• W2017191741 cites W2139319526 @default.
• W2017191741 cites W2152788288 @default.
• W2017191741 cites W2153535934 @default.
• W2017191741 cites W2153804899 @default.
• W2017191741 cites W2325177197 @default.
• W2017191741 cites W2331176038 @default.
• W2017191741 cites W2347194146 @default.
• W2017191741 cites W4211181668 @default.
• W2017191741 cites W53276664 @default.
• W2017191741 doi "https://doi.org/10.1016/s0361-9230(02)00772-4" @default.
• W2017191741 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12128152" @default.
• W2017191741 hasPublicationYear "2002" @default.
• W2017191741 type Work @default.
• W2017191741 sameAs 2017191741 @default.
• W2017191741 citedByCount "42" @default.
• W2017191741 countsByYear W20171917412012 @default.
• W2017191741 countsByYear W20171917412013 @default.
• W2017191741 countsByYear W20171917412014 @default.
• W2017191741 countsByYear W20171917412015 @default.
• W2017191741 countsByYear W20171917412016 @default.
• W2017191741 countsByYear W20171917412018 @default.
• W2017191741 countsByYear W20171917412019 @default.
• W2017191741 countsByYear W20171917412020 @default.
• W2017191741 countsByYear W20171917412022 @default.
• W2017191741 countsByYear W20171917412023 @default.
• W2017191741 crossrefType "journal-article" @default.
• W2017191741 hasAuthorship W2017191741A5002673572 @default.
• W2017191741 hasAuthorship W2017191741A5012953142 @default.
• W2017191741 hasAuthorship W2017191741A5013614593 @default.
• W2017191741 hasAuthorship W2017191741A5089404274 @default.
• W2017191741 hasConcept C113045295 @default.
• W2017191741 hasConcept C120770815 @default.
• W2017191741 hasConcept C123012128 @default.
• W2017191741 hasConcept C126322002 @default.
• W2017191741 hasConcept C134018914 @default.
• W2017191741 hasConcept C164027704 @default.
• W2017191741 hasConcept C180899940 @default.
• W2017191741 hasConcept C185592680 @default.
• W2017191741 hasConcept C190283241 @default.
• W2017191741 hasConcept C202751555 @default.
• W2017191741 hasConcept C204232928 @default.
• W2017191741 hasConcept C2776436680 @default.
• W2017191741 hasConcept C2776914184 @default.
• W2017191741 hasConcept C2777851122 @default.
• W2017191741 hasConcept C2778163477 @default.
• W2017191741 hasConcept C2779411790 @default.
• W2017191741 hasConcept C55493867 @default.
• W2017191741 hasConcept C61322309 @default.
• W2017191741 hasConcept C71924100 @default.
• W2017191741 hasConcept C86803240 @default.
• W2017191741 hasConcept C98274493 @default.
• W2017191741 hasConceptScore W2017191741C113045295 @default.
• W2017191741 hasConceptScore W2017191741C120770815 @default.
• W2017191741 hasConceptScore W2017191741C123012128 @default.

• next